Allyson Guidroz - Feb 16, 2025 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Accounting Officer
Signature
/s/ Jennifer Guckert Griffin, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Feb 16, 2025
Transactions value $
-$23,520
Form type
4
Date filed
2/19/2025, 09:21 PM
Previous filing
Aug 2, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +2.16K +24.28% $0.00 11.1K Feb 16, 2025 Direct F1
transaction AMED Common Stock Tax liability -$23.5K -254 -2.3% $92.60 10.8K Feb 16, 2025 Direct
holding AMED Common Stock 1.5 Feb 16, 2025 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 2,160 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 25% on each of February 16, 2026 and February 16, 2027 and 50% on February 16, 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The information in this report is based on a plan statement dated as of December 31, 2024.